Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Wellness Market News: Vitamin Shoppe Loyalty Program Relaunch, Used At-Home Test Strips On Market, More

Executive Summary

More ED-spiked coffee recalled; used, unapproved at-home tests on market; trade group unity in "Day On The Hill"; and Bronze, Silver, Gold Healthy Awards At Vitamin Shoppe.

You may also be interested in...

Vitamin Shoppe Considers Takeover Bid 'Likely Superior' To Current $208m Offer

Firm says following Liberty Tax' offers in early August, it received a second one that "is reasonably likely to lead to" a better deal.Vitamin Shoppe "intends to engage in negotiations with the" second bidder regarding but its board "expressly reaffirms its recommendation" to accept Liberty Tax' offer.

Vitamin Shoppe's Buyer Took Tumultuous Path Toward Recent Turn To Investing

Liberty Tax, which owns tax-return preparation business Liberty Tax Services and branched into capital investing in July, agrees to pay $6.50 per Vitamin Shoppe share, a 43% premium on its closing price a day earlier. Vitamin Shoppe's earnings struggles continued in Q2 as total sales fell 7.6% to $270.9m and it reported a $3.6m net loss after generating $5.3m net income a year ago.

ED-Spiked Honey Among Latest Consumer Health Recalls

Latest updates to FDA's recalls list also includes four OTC eye drop products from MSM Nutraceuticals the agency says are not terminally sterilized and not tested per US Pharmacopeia standards, and Estee Lauder Clinique Laboratories brand Repairwear Laser Focus Line Smoothing Cream Broad Spectrum SPF 15 due to a defective container.

Related Content


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts